VAC-3S
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for VAC-3S, covering 2015-02-02 to 2016-06-17. Get the full timeline:
Most recent: Clinical Trial Update: Open-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1 [Phase 1, Phase 2]